News and Press Releases

pharmaand GmbH Receives Positive CHMP Opinion for Rubraca (rucaparib) as a First-Line Maintenance Treatment in Advanced Ovarian Cancer

CHMP positive opinion based on the results from Phase 3 ATHENA-MONO trial European Commission (EC) approval decision expected in the coming months This is the first rucaparibregulatory milestone since being...

Category: Pharmaceutical
Posted: October 17, 2023

pharmaand GmbH Taborstraße 1 1020 Wien, Austria